Literature DB >> 23383362

Diagnosis and management of bacterial infections in decompensated cirrhosis.

Maria Pleguezuelo1, Jose Manuel Benitez, Juan Jurado, Jose Luis Montero, Manuel De la Mata.   

Abstract

Bacterial infections are one of the most frequent complications in cirrhosis and result in high mortality rates. Patients with cirrhosis have altered and impaired immunity, which favours bacterial translocation. Episodes of infections are more frequent in patients with decompensated cirrhosis than those with compensated liver disease. The most common and life-threatening infection in cirrhosis is spontaneous bacterial peritonitis followed by urinary tract infections, pneumonia, endocarditis and skin and soft-tissue infections. Patients with decompensated cirrhosis have increased risk of developing sepsis, multiple organ failure and death. Risk factors associated with the development of infections are severe liver failure, variceal bleeding, low ascitic protein level and prior episodes of spontaneous bacterial peritonitis (SBP). The prognosis of these patients is closely related to a prompt and accurate diagnosis. An appropriate treatment decreases the mortality rates. Preventive strategies are the mainstay of the management of these patients. Empirical antibiotics should be started immediately following the diagnosis of SBP and the first-line antibiotic treatment is third-generation cephalosporins. However, the efficacy of currently recommended empirical antibiotic therapy is very low in nosocomial infections including SBP, compared to community-acquired episodes. This may be associated with the emergence of infections caused by Enterococcus faecium and extended-spectrum β-lactamase-producing Enterobacteriaceae, which are resistant to the first line antimicrobial agents used for treatment. The emergence of resistant bacteria, underlines the need to restrict the use of prophylactic antibiotics to patients with the greatest risk of infections. Nosocomial infections should be treated with wide spectrum antibiotics. Further studies of early diagnosis, prevention and treatment are needed to improve the outcomes in patients with decompensated cirrhosis.

Entities:  

Keywords:  Antibiotics; Ascites; Cirrhosis; Infections; Spontaneous bacterial peritonitis

Year:  2013        PMID: 23383362      PMCID: PMC3562722          DOI: 10.4254/wjh.v5.i1.16

Source DB:  PubMed          Journal:  World J Hepatol


  97 in total

Review 1.  Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.

Authors:  A Rimola; G García-Tsao; M Navasa; L J Piddock; R Planas; B Bernard; J M Inadomi
Journal:  J Hepatol       Date:  2000-01       Impact factor: 25.083

Review 2.  Spontaneous bacterial peritonitis: recent guidelines and beyond.

Authors:  R Wiest; A Krag; A Gerbes
Journal:  Gut       Date:  2011-12-06       Impact factor: 23.059

3.  Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study.

Authors:  M Borzio; F Salerno; L Piantoni; M Cazzaniga; P Angeli; F Bissoli; S Boccia; G Colloredo-Mels; P Corigliano; G Fornaciari; G Marenco; R Pistarà; M Salvagnini; A Sangiovanni
Journal:  Dig Liver Dis       Date:  2001 Jan-Feb       Impact factor: 4.088

4.  Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis.

Authors:  T M Bauer; B Steinbrückner; F E Brinkmann; A K Ditzen; H Schwacha; J J Aponte; K Pelz; M Kist; H E Blum
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

5.  Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.

Authors:  Javier Fernández; Miquel Navasa; Juliá Gómez; Jordi Colmenero; Jordi Vila; Vicente Arroyo; Juan Rodés
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

Review 6.  Efficacy and safety of tigecycline: a systematic review and meta-analysis.

Authors:  Dafna Yahav; Adi Lador; Mical Paul; Leonard Leibovici
Journal:  J Antimicrob Chemother       Date:  2011-06-18       Impact factor: 5.790

7.  Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients.

Authors:  E Ricart; G Soriano; M T Novella; J Ortiz; M Sàbat; L Kolle; J Sola-Vera; J Miñana; J M Dedéu; C Gómez; J L Barrio; C Guarner
Journal:  J Hepatol       Date:  2000-04       Impact factor: 25.083

8.  Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis.

Authors:  Tilman Martin Bauer; Javier Fernández; Miquel Navasa; Jordi Vila; Juan Rodés
Journal:  J Hepatol       Date:  2002-04       Impact factor: 25.083

9.  Prevention and management of bacterial infections in cirrhosis.

Authors:  Sunil K Taneja; Radha K Dhiman
Journal:  Int J Hepatol       Date:  2011-08-28

10.  Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients.

Authors:  John F Pohl; Raza Patel; Jeffery T Zobell; Ellen Lin; E Kent Korgenski; Kody Crowell; Mark W Mackay; Aleesha Richman; Christian Larsen; Barbara A Chatfield
Journal:  Gastroenterol Res Pract       Date:  2011-11-15       Impact factor: 2.260

View more
  19 in total

1.  CT findings in acute peritonitis: a pattern-based approach.

Authors:  Antonella Filippone; Roberta Cianci; Andrea Delli Pizzi; Gianluigi Esposito; Pierluigi Pulsone; Alessandra Tavoletta; Mauro Timpani; Antonio Raffaele Cotroneo
Journal:  Diagn Interv Radiol       Date:  2015 Nov-Dec       Impact factor: 2.630

2.  Appropriate empirical antibiotic use and 30-d mortality in cirrhotic patients with bacteremia.

Authors:  Hyun Park; Ki Jun Jang; Won Jang; Sang Hoon Park; Ji Young Park; Tae Joo Jeon; Tae Hoon Oh; Won Chang Shin; Won-Choong Choi; Dong Hyun Sinn
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 3.  Multi-resistant bacteria in spontaneous bacterial peritonitis: a new step in management?

Authors:  Angelo Alves de Mattos; Ane Micheli Costabeber; Livia Caprara Lionço; Cristiane Valle Tovo
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 4.  A bridge for short-chain fatty acids to affect inflammatory bowel disease, type 1 diabetes, and non-alcoholic fatty liver disease positively: by changing gut barrier.

Authors:  Wangxin Liu; Xianliang Luo; Jun Tang; Qiufen Mo; Hao Zhong; Hui Zhang; Fengqin Feng
Journal:  Eur J Nutr       Date:  2020-11-12       Impact factor: 5.614

5.  Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae: a retrospective cohort study.

Authors:  Min Jae Kim; Kyoung-Ho Song; Nak-Hyun Kim; Pyoeng Gyun Choe; Wan Beom Park; Ji Hwan Bang; Eu Suk Kim; Sang Won Park; Hong Bin Kim; Hyo-Suk Lee; Myoung-Don Oh; Nam Joong Kim
Journal:  Hepatol Int       Date:  2014-06-08       Impact factor: 6.047

6.  Multiresistant bacterial infections in liver cirrhosis: Clinical impact and new empirical antibiotic treatment policies.

Authors:  Juan Acevedo
Journal:  World J Hepatol       Date:  2015-05-08

7.  An Insight into Antibiotic Resistance to Bacterial Infection in Chronic Liver Disease.

Authors:  Mayank Jain; Joy Varghese; Tom Michael; Chandan Kumar Kedarishetty; Balajee G; Subramanian Swaminathan; Jayanthi Venkataraman
Journal:  J Clin Exp Hepatol       Date:  2017-05-15

8.  Measurement of serum procalcitonin levels for the early diagnosis of spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis.

Authors:  Zhao-Hua Cai; Chun-Lei Fan; Jun-Fu Zheng; Xin Zhang; Wen-Min Zhao; Bing Li; Lei Li; Pei-Ling Dong; Hui-Guo Ding
Journal:  BMC Infect Dis       Date:  2015-02-13       Impact factor: 3.090

9.  Liver abscesses after peritoneal venous shunt.

Authors:  Hideto Kawaratani; Tatsuhiro Tsujimoto; Takuya Kubo; Yousuke Aihara; Toshiaki Takaya; Masakazu Uejima; Kei Moriya; Ryuichi Noguchi; Hitoshi Yoshiji; Hiroshi Fukui
Journal:  Case Rep Gastroenterol       Date:  2013-05-28

10.  Evolving epidemiology and antimicrobial resistance in spontaneous bacterial peritonitis: a two-year observational study.

Authors:  Lionel Piroth; André Pechinot; Vincent Di Martino; Yves Hansmann; Alain Putot; Isabelle Patry; Tahar Hadou; Benoit Jaulhac; Catherine Chirouze; Christian Rabaud; Alain Lozniewski; Catherine Neuwirth; Pascal Chavanet; Anne Minello
Journal:  BMC Infect Dis       Date:  2014-05-23       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.